Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours

Sjoukje F Oosting; Astrid A M van der Veldt; Rudolf S N Fehrmann; Corine H GeurtsvanKessel; Rob S van Binnendijk; Anne-Marie C Dingemans; Egbert F Smit; T Jeroen N Hiltermann; Gerco den Hartog; Mathilda Jalving; Tatjana T Westphal; Arkajyoti Bhattacharya; Faye de Wilt; Annemarie Boerma; Lisanne van Zijl; Guus F Rimmelzwaan; Pia Kvistborg; Cecile A C M van Els; Nynke Y Rots; Debbie van Baarle; John B A G Haanen; Elisabeth G E de Vries

doi:10.1016/S1470-2045(22)00203-0

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours

Sjoukje F Oosting, Astrid A M van der Veldt^*, Rudolf S N Fehrmann, Corine H GeurtsvanKessel, Rob S van Binnendijk, Anne-Marie C Dingemans, Egbert F Smit, T Jeroen N Hiltermann, Gerco den Hartog, Mathilda Jalving, Tatjana T Westphal, Arkajyoti Bhattacharya, Faye de Wilt, Annemarie Boerma, Lisanne van Zijl, Guus F Rimmelzwaan, Pia Kvistborg, Cecile A C M van Els, Nynke Y Rots, Debbie van BaarleJohn B A G Haanen, Elisabeth G E de Vries

^*Corresponding author for this work

Translational Immunology Groningen (TRIGR)

Research output: Contribution to journal › Letter › Academic › peer-review

18 Citations (Scopus)

73 Downloads (Pure)

Original language	English
Pages (from-to)	833-835
Number of pages	3
Journal	Lancet Oncology
Volume	23
Issue number	7
Early online date	25-Apr-2022
DOIs	https://doi.org/10.1016/S1470-2045(22)00203-0
Publication status	Published - Jul-2022

Access to Document

10.1016/S1470-2045(22)00203-0

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumoursFinal publisher's version, 388 KBLicence: Taverne

Handle.net

Persistent link

Cite this

Oosting, S. F., van der Veldt, A. A. M., Fehrmann, R. S. N., GeurtsvanKessel, C. H., van Binnendijk, R. S., Dingemans, A.-M. C., Smit, E. F., Hiltermann, T. J. N., den Hartog, G., Jalving, M., Westphal, T. T., Bhattacharya, A., de Wilt, F., Boerma, A., van Zijl, L., Rimmelzwaan, G. F., Kvistborg, P., van Els, C. A. C. M., Rots, N. Y., ... de Vries, E. G. E. (2022). Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours. Lancet Oncology, 23(7), 833-835. https://doi.org/10.1016/S1470-2045(22)00203-0

@article{2fa86b3d4f7644d18288ffcaa3e8c8b1,

title = "Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours",

author = "Oosting, {Sjoukje F} and {van der Veldt}, {Astrid A M} and Fehrmann, {Rudolf S N} and GeurtsvanKessel, {Corine H} and {van Binnendijk}, {Rob S} and Dingemans, {Anne-Marie C} and Smit, {Egbert F} and Hiltermann, {T Jeroen N} and {den Hartog}, Gerco and Mathilda Jalving and Westphal, {Tatjana T} and Arkajyoti Bhattacharya and {de Wilt}, Faye and Annemarie Boerma and {van Zijl}, Lisanne and Rimmelzwaan, {Guus F} and Pia Kvistborg and {van Els}, {Cecile A C M} and Rots, {Nynke Y} and {van Baarle}, Debbie and Haanen, {John B A G} and {de Vries}, {Elisabeth G E}",

year = "2022",

month = jul,

doi = "10.1016/S1470-2045(22)00203-0",

language = "English",

volume = "23",

pages = "833--835",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "ELSEVIER SCIENCE INC",

number = "7",

}

Oosting, SF, van der Veldt, AAM, Fehrmann, RSN, GeurtsvanKessel, CH, van Binnendijk, RS, Dingemans, A-MC, Smit, EF, Hiltermann, TJN, den Hartog, G, Jalving, M, Westphal, TT, Bhattacharya, A, de Wilt, F, Boerma, A, van Zijl, L, Rimmelzwaan, GF, Kvistborg, P, van Els, CACM, Rots, NY, van Baarle, D, Haanen, JBAG & de Vries, EGE 2022, 'Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours', Lancet Oncology, vol. 23, no. 7, pp. 833-835. https://doi.org/10.1016/S1470-2045(22)00203-0

TY - JOUR

T1 - Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours

AU - Oosting, Sjoukje F

AU - van der Veldt, Astrid A M

AU - Fehrmann, Rudolf S N

AU - GeurtsvanKessel, Corine H

AU - van Binnendijk, Rob S

AU - Dingemans, Anne-Marie C

AU - Smit, Egbert F

AU - Hiltermann, T Jeroen N

AU - den Hartog, Gerco

AU - Jalving, Mathilda

AU - Westphal, Tatjana T

AU - Bhattacharya, Arkajyoti

AU - de Wilt, Faye

AU - Boerma, Annemarie

AU - van Zijl, Lisanne

AU - Rimmelzwaan, Guus F

AU - Kvistborg, Pia

AU - van Els, Cecile A C M

AU - Rots, Nynke Y

AU - van Baarle, Debbie

AU - Haanen, John B A G

AU - de Vries, Elisabeth G E

PY - 2022/7

Y1 - 2022/7

U2 - 10.1016/S1470-2045(22)00203-0

DO - 10.1016/S1470-2045(22)00203-0

M3 - Letter

C2 - 35483383

SN - 1470-2045

VL - 23

SP - 833

EP - 835

JO - Lancet Oncology

JF - Lancet Oncology

IS - 7

ER -